MeiraGTx Holdings (MGTX) Cash & Equivalents (2017 - 2025)
MeiraGTx Holdings (MGTX) posted Cash & Equivalents of $65.9 million for Q4 2025, up 344.25% on a QoQ basis from $14.8 million in Q3 2025, and down 36.4% year-over-year from $103.7 million in Q4 2024.
MeiraGTx Holdings (MGTX) Cash & Equivalents (2017 - 2025) Analysis & Trends
MeiraGTx Holdings' Cash & Equivalents history runs 9 years deep, the most recent figure standing at $65.9 million for Q4 2025.
- Quarterly Cash & Equivalents fell 36.4% year-over-year to $65.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $65.9 million (down 36.4% YoY) and the FY2025 annual result came in at $65.9 million, down 36.4% from the prior year.
- Cash & Equivalents was $65.9 million for Q4 2025 at MeiraGTx Holdings, up from $14.8 million in the prior quarter.
- Across five years, Cash & Equivalents topped out at $199.4 million in Q1 2021 and bottomed at $14.8 million in Q3 2025.
- A 5-year average of $102.8 million and a median of $108.7 million in 2022 frame the typical range for Cash & Equivalents.
- Annual changes were most pronounced in 2024 — Cash & Equivalents surged 94.14% — and 2025, when it slumped 88.13%.
- MeiraGTx Holdings' Cash & Equivalents stood at $137.7 million in 2021, then slipped by 16.11% to $115.5 million in 2022, then gained by 13.1% to $130.6 million in 2023, then declined by 20.66% to $103.7 million in 2024, then slumped by 36.4% to $65.9 million in 2025.
- Business Quant data shows MGTX's Cash & Equivalents at $65.9 million in Q4 2025, $14.8 million in Q3 2025, and $32.2 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 82.45 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 5.49 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.96 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 3.58 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 440.94 Mn |
| 10 | MeiraGTx Holdings | 973.21 Mn | 907.27 Mn | - | 65.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 65.93 Mn |
| Sep 30, 2025 | 14.84 Mn |
| Jun 30, 2025 | 32.17 Mn |
| Mar 31, 2025 | 66.52 Mn |
| Dec 31, 2024 | 103.66 Mn |
| Sep 30, 2024 | 125.03 Mn |
| Jun 30, 2024 | 101.03 Mn |
| Mar 31, 2024 | 120.27 Mn |
| Dec 31, 2023 | 130.65 Mn |
| Sep 30, 2023 | 64.40 Mn |
| Jun 30, 2023 | 92.77 Mn |
| Mar 31, 2023 | 68.78 Mn |
| Dec 31, 2022 | 115.52 Mn |
| Sep 30, 2022 | 114.71 Mn |
| Jun 30, 2022 | 72.10 Mn |
| Mar 31, 2022 | 113.78 Mn |
| Dec 31, 2021 | 137.70 Mn |
| Sep 30, 2021 | 143.63 Mn |
| Jun 30, 2021 | 172.56 Mn |
| Mar 31, 2021 | 199.41 Mn |